Fabio Franco - Publications

Advanced non-squamous NSCLC with no actionable oncogenic driver in Spain: a cross-sectional descriptive analysis of data from the Thoracic Tumor Registry.

Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico

Published: March 06, 2024

Clinical factors influencing long-term survival in a real-life cohort of early stage non-small-cell lung cancer patients in Spain.

Journal: Frontiers in oncology

Published: October 19, 2022

Understanding prognosis and survival outcomes in patients with early-stage non-small-cell lung cancer.

Journal: Clinical medicine (London, England)

Published: October 11, 2022

Association of quality of life with performance status, circadian rhythm, and activity level of lung cancer patients using wearable devices as ambulatory monitoring.

Journal: Clinical medicine (London, England)

Published: October 11, 2022

Assessing the risk of cardiovascular events in patients receiving immune checkpoint inhibitors.

Journal: Frontiers in cardiovascular medicine

Published: October 06, 2022

Molecular Divergence upon EGFR-TKI Resistance Could Be Dependent on the Exon Location of the Original EGFR-Sensitizing Mutation.

Journal: Cancers

Published: August 19, 2022

On Predicting Recurrence in Early Stage Non-small Cell Lung Cancer.

Journal: AMIA ... Annual Symposium proceedings. AMIA Symposium

Published: March 21, 2022

Chronodisruption and Ambulatory Circadian Monitoring in Cancer Patients: Beyond the Body Clock.

Journal: Current oncology reports

Published: September 16, 2021

To burn-out or not to burn-out: a cross-sectional study in healthcare professionals in Spain during COVID-19 pandemic.

Journal: BMJ open

Published: February 25, 2021

Integrating immune checkpoint inhibitors and targeted therapies in the treatment of early stage non-small cell lung cancer: a narrative review.

Journal: Translational lung cancer research

Published: January 25, 2021

Analysis of circulating tumour DNA to identify patients with epidermal growth factor receptor-positive non-small cell lung cancer who might benefit from sequential tyrosine kinase inhibitor treatment.

Journal: European journal of cancer (Oxford, England : 1990)

Published: September 07, 2020

Some unanswered questions about older adults with metastatic pancreatic cancer.

Journal: Journal of geriatric oncology

Published: February 17, 2020